<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1906">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05136352</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/21/0167</org_study_id>
    <secondary_id>2021-A01226-35</secondary_id>
    <nct_id>NCT05136352</nct_id>
  </id_info>
  <brief_title>Postoperative Analgesic Benefit of iPACK Block in the Anterior Cruciate Ligament Reconstruction Surgery</brief_title>
  <acronym>Liga-PACK</acronym>
  <official_title>Postoperative Analgesic Benefit of iPACK Block in the Anterior Cruciate Ligament Reconstruction Surgery, the LIGA-PACK Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomised clinical trial evaluates the analgesia provided by an iPack block associated&#xD;
      with an adductor canal block in patients who undergo anterior cruciate ligament&#xD;
      reconstruction surgery, compared to an adductor canal block alone. The objective is to prove&#xD;
      the superiority of this locoregional anesthesia in terms of analgesia and functional&#xD;
      rehabilitation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ideal loco-regional anesthesia for anterior cruciate ligament reconstruction ensuring a&#xD;
      satisfying analgesia without compromising an early rehabilitation is still undetermined.&#xD;
&#xD;
      Femoral nerve block has been incriminated in a delayed postoperative mobilization whereas the&#xD;
      adductor canal block gives an equivalent analgesia for a better preservation of the&#xD;
      quadricipital muscular strength.&#xD;
&#xD;
      The iPACK block (infiltration between the popliteal artery and the capsule of the posterior&#xD;
      knee) is a recently described technique. Few studies have assessed the iPACK block in ACL&#xD;
      reconstruction, and none were randomized.&#xD;
&#xD;
      This randomized single blind clinical trial compares two groups of 45 patients who undergo&#xD;
      ACL reconstruction surgery under general anaesthetic : one receives an iPACK block associated&#xD;
      with an adductor canal block, and the other only has an adductor canal block.&#xD;
&#xD;
      Pain scores and opioid consumption are collected after surgery in the recovery room, then by&#xD;
      telephone interview at 24 and 48 hours post-surgery. Functional rehabilitation is evaluated&#xD;
      by scales (KOOS, LYSHOLM and iKDC) at 3, 6 and 9 months after surgery. Adverse effects, due&#xD;
      to anesthesia or opioids, are collected from 30 min after loco-regional anesthesia until the&#xD;
      second phone call at 48h post-surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">October 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative opioid consumption at 48 hours after surgery</measure>
    <time_frame>Hours 48</time_frame>
    <description>Cumulative opioid consumption in the first 48 hours after anterior cruciate ligament repair surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cumulative opioid consumption at 2 hours after surgery</measure>
    <time_frame>Hours 2</time_frame>
    <description>Cumulative opioid consumption in the recovery room after anterior cruciate ligament repair surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative opioid consumption at 24 hours after surgery</measure>
    <time_frame>Hours 24</time_frame>
    <description>Cumulative opioid consumption in the first 24 hours after anterior cruciate ligament repair surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative opioid consumption at 3 months</measure>
    <time_frame>month 3</time_frame>
    <description>total opioid consumption at 3 months after anterior cruciate ligament repair surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum pain score in the recovery room</measure>
    <time_frame>hours 2</time_frame>
    <description>Maximum pain score evaluated by the numerical pain scale from 0 to 10 (0 lowest pain score / 10 highest pain score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum pain score at 24 hours after surgery</measure>
    <time_frame>hours 24</time_frame>
    <description>Maximum pain score evaluated by the numerical pain scale from 0 to 10 (0 lowest pain score / 10 highest pain score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum pain score at 48 hours after surgery</measure>
    <time_frame>hours 48</time_frame>
    <description>Maximum pain score evaluated by the numerical pain scale from 0 to 10 (0 lowest pain score / 10 highest pain score)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Anesthesia</condition>
  <condition>Anterior Cruciate Ligament Reconstruction</condition>
  <arm_group>
    <arm_group_label>adductor canal block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>loco-regional analgesia with adductor canal block (ACB) method (for anterior cruciate ligament reconstruction )</description>
  </arm_group>
  <arm_group>
    <arm_group_label>iPACK block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>loco-regional analgesia with iPACK block (infiltration between the popliteal artery and the capsule of the posterior knee) ((for anterior cruciate ligament reconstruction )</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>adductor canal block</intervention_name>
    <description>loco-regional anesthesia using adductor canal block</description>
    <arm_group_label>adductor canal block</arm_group_label>
    <other_name>ACB</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>iPACK block</intervention_name>
    <description>loco-regional anesthesia using infiltration between the popliteal artery and the capsule of the posterior knee</description>
    <arm_group_label>iPACK block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  ACL repair surgery under general anesthesia&#xD;
&#xD;
          -  Person affiliated or beneficiary of a social security plan&#xD;
&#xD;
          -  Free, informed and written consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 18 years&#xD;
&#xD;
          -  Contraindication to ALR (allergy to local anesthetics, local infection of the puncture&#xD;
             site, coagulopathy)&#xD;
&#xD;
          -  Pre-existing opiate dependence&#xD;
&#xD;
          -  Contraindication to non-steroidal anti-inflammatory drugs&#xD;
&#xD;
          -  Pregnant or potentially pregnant women&#xD;
&#xD;
          -  Patients under the protection of adults (guardianship, curatorship or safeguard of&#xD;
             justice)&#xD;
&#xD;
          -  Patients whose cognitive state does not allow evaluation by the scales used&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrice FERRE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabrice FERRÉ, MD</last_name>
    <phone>05-61-77-99-88</phone>
    <phone_ext>+33</phone_ext>
    <email>ferre.f@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>FERRE</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Fabrice FERRE, PH</last_name>
    </contact>
    <investigator>
      <last_name>Fabrice FERRE, PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 20, 2021</study_first_submitted>
  <study_first_submitted_qc>November 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>loco-regional anesthesia</keyword>
  <keyword>anterior cruciate ligament reconstruction</keyword>
  <keyword>multimodal analgesia</keyword>
  <keyword>motor sparing</keyword>
  <keyword>iPACK block</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

